Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Gross Profit: 2023-2024

Historic Gross Profit for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $251,000.

  • Artiva Biotherapeutics' Gross Profit was N/A to $251,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $30.2 million, marking a year-over-year change of. This contributed to the annual value of $251,000 for FY2024, which is 99.25% down from last year.
  • As of FY2024, Artiva Biotherapeutics' Gross Profit stood at $251,000, which was down 99.25% from $33.5 million recorded in FY2023.
  • In the past 5 years, Artiva Biotherapeutics' Gross Profit registered a high of $33.5 million during FY2023, and its lowest value of $251,000 during FY2024.
  • For the 2-year period, Artiva Biotherapeutics' Gross Profit averaged around $16.9 million, with its median value being $16.9 million (2023).
  • Data for Artiva Biotherapeutics' Gross Profit shows a maximum YoY crashed of 99.25% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' Gross Profit (Yearly) stood at $33.5 million in 2023, then slumped by 99.25% to $251,000 in 2024.